Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Psychopharmacology|April 18, 2016
Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis usersEvan S Herrmann, Ziva D Cooper, Gillinder Bedi, et al.Addiction Biology|November 1, 2018
Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapseEvan S Herrmann, Ziva D Cooper, Gillinder Bedi, et al.Drug and Alcohol Dependence|April 17, 2020
Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabisNicolas J Schlienz, Tory R Spindle, Edward J Cone, et al.Addiction Biology|June 27, 2022
Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokersMargaret Haney, Gillinder Bedi, Ziva D Cooper, et al.Experimental and Clinical Psychopharmacology|May 29, 2020
Impact of smoked cannabis on tobacco cigarette smoking intensity and subjective effects: A placebo-controlled, double-blind, within-subjects human laboratory studyErica N Peters, Evan S Herrmann, Carson Smith, et al.International Review of Psychiatry (Abingdon, England)|September 5, 2018
Sweet flowers are slow, and weeds make haste: leveraging methodology from research on tobacco, alcohol, and opioid analgesics to make rapid and policy-relevant advances in cannabis scienceEvan S Herrmann, Brantley P Jarvis, Alicia C Sparks, et al.Journal of Analytical Toxicology|January 5, 2018
Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy AdultsNicolas J Schlienz, Edward J Cone, Evan S Herrmann, et al.Journal of Substance Use and Addiction Treatment|October 6, 2023
Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorderDustin C Lee, Nicolas J Schlienz, Evan S Herrmann, et al.The Journal of Pharmacology and Experimental Therapeutics|May 22, 2009
Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock periodKevin M Walton, Katherine Fisher, David Rubitski, et al.Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymesQing-Jun Meng, Elizabeth S Maywood, David A Bechtold, et al.Pageof 5